Drugs Made In Stock Market Value
| DMAA Stock | 10.27 0.04 0.39% |
| Symbol | Drugs |
Is Trading space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Drugs Made 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Drugs Made's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Drugs Made.
| 04/23/2025 |
| 07/22/2025 |
If you would invest 0.00 in Drugs Made on April 23, 2025 and sell it all today you would earn a total of 0.00 from holding Drugs Made In or generate 0.0% return on investment in Drugs Made over 90 days. Drugs Made is related to or competes with YHN Acquisition, YHN Acquisition, CO2 Energy, CO2 Energy, Vine Hill, and Roman DBDR. More
Drugs Made Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Drugs Made's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Drugs Made In upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1278 | |||
| Information Ratio | (1.05) | |||
| Maximum Drawdown | 0.6851 | |||
| Value At Risk | (0.1) | |||
| Potential Upside | 0.1992 |
Drugs Made Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Drugs Made's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Drugs Made's standard deviation. In reality, there are many statistical measures that can use Drugs Made historical prices to predict the future Drugs Made's volatility.| Risk Adjusted Performance | 0.164 | |||
| Jensen Alpha | 0.0178 | |||
| Total Risk Alpha | 0.0022 | |||
| Sortino Ratio | (0.92) | |||
| Treynor Ratio | 4.02 |
Drugs Made In Backtested Returns
At this point, Drugs Made is very steady. Drugs Made In secures Sharpe Ratio (or Efficiency) of 0.29, which denotes the company had a 0.29 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Drugs Made In, which you can use to evaluate the volatility of the firm. Please confirm Drugs Made's Coefficient Of Variation of 392.49, mean deviation of 0.0849, and Standard Deviation of 0.1117 to check if the risk estimate we provide is consistent with the expected return of 0.0327%. Drugs Made has a performance score of 23 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0046, which means not very significant fluctuations relative to the market. As returns on the market increase, Drugs Made's returns are expected to increase less than the market. However, during the bear market, the loss of holding Drugs Made is expected to be smaller as well. Drugs Made In right now shows a risk of 0.11%. Please confirm Drugs Made In treynor ratio, downside variance, kurtosis, as well as the relationship between the value at risk and expected short fall , to decide if Drugs Made In will be following its price patterns.
Auto-correlation | 0.85 |
Very good predictability
Drugs Made In has very good predictability. Overlapping area represents the amount of predictability between Drugs Made time series from 23rd of April 2025 to 7th of June 2025 and 7th of June 2025 to 22nd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Drugs Made In price movement. The serial correlation of 0.85 indicates that around 85.0% of current Drugs Made price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.85 | |
| Spearman Rank Test | 0.96 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Drugs Made In lagged returns against current returns
Autocorrelation, which is Drugs Made stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Drugs Made's stock expected returns. We can calculate the autocorrelation of Drugs Made returns to help us make a trade decision. For example, suppose you find that Drugs Made has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Drugs Made regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Drugs Made stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Drugs Made stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Drugs Made stock over time.
Current vs Lagged Prices |
| Timeline |
Drugs Made Lagged Returns
When evaluating Drugs Made's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Drugs Made stock have on its future price. Drugs Made autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Drugs Made autocorrelation shows the relationship between Drugs Made stock current value and its past values and can show if there is a momentum factor associated with investing in Drugs Made In.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Drugs Made In is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Drugs Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Drugs Made In Stock. Highlighted below are key reports to facilitate an investment decision about Drugs Made In Stock:Check out Drugs Made Correlation, Drugs Made Volatility and Drugs Made Alpha and Beta module to complement your research on Drugs Made. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Drugs Made technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.